KCNMA1-linked channelopathy.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• The KCNMA1 gene encodes the alpha subunit of the large conductance calcium and voltage-activated potassium (BK) channel.
• BK channels are vital for neuronal excitability and muscle contractility, with critical roles in the brain and muscles.
• While mouse models show BK channel importance, human consequences of dysfunctional BK channels are less understood.

Purpose of the Study:

• To summarize KCNMA1 mutations in patients and characterize KCNMA1-linked channelopathy.
• To investigate the association between BK channel function (GOF, LOF, VUS) and specific patient phenotypes.
• To highlight the need for further research into BK channel roles in cell excitability and potential therapeutic targets.

Main Methods:

• Review of 16 rare KCNMA1 mutations identified in 37 patients since 2005.
• Clinical phenotyping of patients with KCNMA1 mutations.
• Analysis of functional consequences (gain-of-function, loss-of-function, variants of unknown significance) of identified KCNMA1 mutations.

Main Results:

• 16 rare KCNMA1 mutations were identified in 37 patients, causing KCNMA1-linked channelopathy.
• Human KCNMA1 mutations are primarily linked to neurological disorders, including seizures, movement disorders, developmental delay, and intellectual disability.
• Gain-of-function mutations are associated with paroxysmal nonkinesigenic dyskinesia, while loss-of-function mutations are linked to ataxia.

Conclusions:

• KCNMA1 mutations lead to a spectrum of neurological and muscular symptoms, collectively termed KCNMA1-linked channelopathy.
• Functional alterations in BK channels may correlate with distinct clinical presentations.
• Further research is needed to establish causality and explore novel therapeutic strategies for KCNMA1-linked channelopathy.